Inventor · disambiguated record
Dorothée Alice Marie-Eve Bardiot
Also filed as: BARDIOT DOROTHEE · BARDIOT DOROTHÉE · BARDIOT DOROTHÉE ALICE MARIE-EVE
31 granted patents·7 pending applications·88 citations·filing 2009–2025
95Inventor score
Files withJANSSEN PHARMACEUTICALS INC21ALIGOS THERAPEUTICS INC8UNIV LEUVEN KATH7BARDIOT DOROTHEE1BARDIOT DOROTHÉE1
Top patents by PatentIndex Score
38 records- 0197US11851422B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2022·Granted Dec 26, 2023·8 cites·61 claims
- 0295US10919854B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Feb 16, 2021·3 cites·28 claims
- 0395US9944598B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted Apr 17, 2018·21 cites·17 claims
- 0494US11827602B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 28, 2023·2 cites·11 claims
- 0594US10029984B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Jul 24, 2018·21 cites·5 claims
- 0692US11952365B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2021·Granted Apr 9, 2024·2 cites·18 claims
- 0792US10206902B2Mono- or di-substituted indoles as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted Feb 19, 2019·14 cites·9 claims
- 0891US10696632B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Jun 30, 2020·3 cites·13 claims
- 0989US12065428B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2022·Granted Aug 20, 2024·1 cites·23 claims
- 1089US11180450B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 23, 2021·2 cites·3 claims
- 1189US10689340B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Jun 23, 2020·4 cites·8 claims
- 1288US12172959B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2023·Granted Dec 24, 2024·0 cites·27 claims
- 1388US2025230127A1Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1482US12252481B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Granted Mar 18, 2025·0 cites·23 claims
- 1574US11795149B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Oct 24, 2023·0 cites·13 claims
- 1674US10550123B2Viral replication inhibitorsUNIV LEUVEN KATH·Filed 2012·Granted Feb 4, 2020·3 cites·17 claims
- 1772US8785638B2Thieno [2, 3-B] pyridine derivatives as viral replication inhibitorsBARDIOT DOROTHÉE·Filed 2010·Granted Jul 22, 2014·4 cites·9 claims
- 1869US11702387B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Jul 18, 2023·0 cites·14 claims
- 1969US2025243187A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2068US12012411B2Viral replication inhibitorsUNIV LEUVEN KATH·Filed 2021·Granted Jun 18, 2024·0 cites·18 claims
- 2166US2024199647A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2266US2024182444A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2365US2024018126A1Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2462US11407715B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Aug 9, 2022·0 cites·21 claims
- 2560US11053196B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Jul 6, 2021·0 cites·25 claims
- 2659US11083707B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Aug 10, 2021·0 cites·15 claims
- 2758US10633378B2Viral replication inhibitorsUNIV LEUVEN KATH·Filed 2014·Granted Apr 28, 2020·0 cites·5 claims
- 2857US11279704B2Viral replication inhibitorsUNIV LEUVEN KATH·Filed 2019·Granted Mar 22, 2022·0 cites·53 claims
- 2956US11566025B2Viral replication inhibitorsUNIV LEUVEN KATH·Filed 2020·Granted Jan 31, 2023·0 cites·18 claims
- 3052US10646469B2Substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted May 12, 2020·0 cites·7 claims
- 3152US2011224208A1Novel inhibitors of flavivirus replicationUNIV LEUVEN KATH·Filed 2009·Application pending·0 cites
- 3251US9499563B2Thieno [2, 3-B] pyridine derivatives as viral replication inhibitorsUNIV LEUVEN KATH·Filed 2014·Granted Nov 22, 2016·0 cites·18 claims
- 3350US10913716B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Feb 9, 2021·0 cites·16 claims
- 3448US10765662B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Sep 8, 2020·0 cites·17 claims
- 3545US11179368B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Nov 23, 2021·0 cites·10 claims
- 3644US10786484B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Sep 29, 2020·0 cites·17 claims
- 3737US10730884B2Substituted indole compound derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Aug 4, 2020·0 cites·6 claims
- 3836US2012252801A1Antifungal compoundsBARDIOT DOROTHEE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dorothée Alice Marie-Eve Bardiot files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →